These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 18576928

  • 1. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM, Fox NS, Chasen ST.
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [Abstract] [Full Text] [Related]

  • 2. [Economical impact of preterm delivery management based on fetal fibronectin results].
    García Alonso LA, Ayala Méndez JA, Jiménez Solís G, Aguilar Gutiérrez F, Díaz Cueto L.
    Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
    [Abstract] [Full Text] [Related]

  • 3. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M, Ghidini A, Korker V, Pezzullo JC.
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions.
    Mateus J, Pereira L, Baxter J, Berghella V, Tolosa J.
    Am J Perinatol; 2007 Jun; 24(6):381-5. PubMed ID: 17566945
    [Abstract] [Full Text] [Related]

  • 5. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J, Chedraui P, Hidalgo L, Medina M.
    J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
    [Abstract] [Full Text] [Related]

  • 6. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC, Navas H, Marcos M, Iza A, De Diego M, Rando D, Melchor I, Burgos J.
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [Abstract] [Full Text] [Related]

  • 7. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population.
    Groom KM, Liu E, Allenby K.
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):440-5. PubMed ID: 16953860
    [Abstract] [Full Text] [Related]

  • 8. Effect of digital cervical examination on the expression of fetal fibronectin.
    McKenna DS, Chung K, Iams JD.
    J Reprod Med; 1999 Sep; 44(9):796-800. PubMed ID: 10509304
    [Abstract] [Full Text] [Related]

  • 9. A randomized multicenter study to determine the efficacy of activity restriction for preterm labor management in patients testing negative for fetal fibronectin.
    Elliott JP, Miller HS, Coleman S, Rhea D, Abril D, Hallbauer K, Istwan NB, Stanziano GJ.
    J Perinatol; 2005 Oct; 25(10):626-30. PubMed ID: 16107874
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-8 and glucose in amniotic fluid, fetal fibronectin in vaginal secretions and preterm labor index based on clinical variables are optimal predictive markers for preterm delivery in patients with intact membranes.
    Yoneda S, Sakai M, Sasaki Y, Shiozaki A, Hidaka T, Saito S.
    J Obstet Gynaecol Res; 2007 Feb; 33(1):38-44. PubMed ID: 17212664
    [Abstract] [Full Text] [Related]

  • 11. [Is fetal fibronectin a valid test predictive of premature labor?].
    Mansouri A, Tadjerouni A, El Rabiey G, Baube S, Garnier G, Tribalat S.
    Contracept Fertil Sex; 1997 May; 25(5):380-4. PubMed ID: 9273109
    [Abstract] [Full Text] [Related]

  • 12. Fetal fibronectin as a predictor of spontaneous preterm labour in asymptomatic women with a cervical cerclage.
    Duhig KE, Chandiramani M, Seed PT, Briley AL, Kenyon AP, Shennan AH.
    BJOG; 2009 May; 116(6):799-803. PubMed ID: 19432568
    [Abstract] [Full Text] [Related]

  • 13. Improved management in threatened preterm labour with rapid fetal fibronectin testing.
    Parry E, Singh TG, Dow D, Noovao F.
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):240-1. PubMed ID: 16704480
    [Abstract] [Full Text] [Related]

  • 14. [Quantitative determination of fetal fibronectin in cervical smears: a new marker for evaluating the risk of premature labor].
    Hampl M, Friese K, Hofmann I, Melchert F.
    Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):685-90. PubMed ID: 7851710
    [Abstract] [Full Text] [Related]

  • 15. Clinical utility of fetal fibronectin for predicting preterm birth.
    Swamy GK, Simhan HN, Gammill HS, Heine RP.
    J Reprod Med; 2005 Nov; 50(11):851-6. PubMed ID: 16419634
    [Abstract] [Full Text] [Related]

  • 16. Pregnancy outcome in women with preterm labor symptoms without cervical change.
    Rinehart BK, Terrone DA, Isler CM, Barrilleaux PS, Bufkin L, Morrison JC.
    Am J Obstet Gynecol; 2001 Apr; 184(5):1004-7. PubMed ID: 11303212
    [Abstract] [Full Text] [Related]

  • 17. "Blind" vaginal fetal fibronectin as a predictor of spontaneous preterm delivery.
    Roman AS, Koklanaris N, Paidas MJ, Mulholland J, Levitz M, Rebarber A.
    Obstet Gynecol; 2005 Feb; 105(2):285-9. PubMed ID: 15684153
    [Abstract] [Full Text] [Related]

  • 18. Assessment of rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I, Marek S, Hellmeyer L, Reitz D, Schmidt S.
    Obstet Gynecol; 2005 Feb; 105(2):280-4. PubMed ID: 15684152
    [Abstract] [Full Text] [Related]

  • 19. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, Poston L.
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [Abstract] [Full Text] [Related]

  • 20. Fetal fibronectin for evaluation of preterm labor in the setting of cervical cerclage.
    Benson JE, Landy HJ, Ghidini A, Drassinower D, Poggi SH.
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2330-2. PubMed ID: 22694302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.